Clin Res Cardiol (2021)
DOI DOI https://doi.org/10.1007/s00392-021-01843-w

Associations of standardized risk-adjusted peri-procedural management in catheterization procedures for non-ST-segment elevation myocardial infarction with in-hospital clinical outcomes
C. Parco1, J. Tröstler1, M. Brockmeyer1, Y. Lin1, T. Krieger1, J. Quade1, S. Bader1, L. Kosejian1, A. Karathanos1, Y. Heinen1, A. Icks2, V. Schulze3, M. Kelm1, G. Wolff1
1Klinik für Kardiologie, Pneumologie und Angiologie, Universitätsklinikum Düsseldorf, Düsseldorf; 2Institut für Versorgungsforschung und Gesunsheitsökonomie, Universitätsklinikum Düsseldorf, Düsseldorf; 3CardioCentrum Düsseldorf, Düsseldorf;

Introduction: Patient risk for adverse events in non-ST-segment myocardial infarction (NSTEMI) depends on procedural characteristics, patients’ comorbidities and clinical setting. We aimed to investigate standardized risk-adjusted periprocedural management for coronary angiographies and evaluate associations of a Standard Operation Procedure (SOP) with in-hospital clinical outcomes. 

Methods: We established pre-procedural risk assessment for cardiac catheterization procedures based on the National Cardiovascular Data Registry (NCDR) risk models at our Heart Center in 2018. Along with pre-procedural risk assessment, standardized post-procedural risk-adjusted safety measures including advanced patient monitoring, the use of vascular closure devices and others were established. We retrospectively evaluated SOP-based risk scoring as well as post-procedural management and in-hospital clinical outcomes for in-hospital mortality, major bleeding (BARC ≥ 3) and acute kidney injury (according to KDIGO definitions) in NSTEMI patients.  

Results: 430 NSTEMI patients presenting with NSTEMI were included (71% male). Overall in-hospital mortality was 3.7%, acute kidney injury was observed in 17.2% and major bleeding in 6.5% of the patients. 207 patients (48.1%) received 1) pre-procedural risk assessment and 2) post-procedural risk-adjusted management (SOP+ group), 223 patients (51.9%) had not received either 1) or 2) (SOP- group). Overall, patients in the SOP- group were more often treated in emergency settings (39.9% (SOP-) vs. 21.7% (SOP+); p<0.001). Baseline characteristics and medical conditions did not differ significantly between groups. In univariate analysis, in-hospital clinical outcomes of mortality (1.4% (SOP+) vs. 5.8% (SOP-); p=0.016), major bleeding (2.9% (SOP+) vs. 9.9% (SOP-); p=0.003) were significantly lower in the SOP+ group, whereas clinical events of acute kidney injury did not differ significantly (14% (SOP+) vs. 20.2% (SOP-); p=0.090). In the multivariate logistic regression analysis with correction for the difference in risk between groups due to emergency settings, major bleedings remained significantly lower in the SOP+ group (p=0.02).

Conclusion: Standardized risk-adjusted peri-procedural management in invasively managed NSTEMI patients was associated with significantly less in-hospital major bleedings. 


https://dgk.org/kongress_programme/jt2021/aP265.html